Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $113.7400 (-0.98%) ($113.0300 - $115.5000) on Wed. Jun. 5, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.56% (three month average) | RSI | 47 | Latest Price | $113.7400(-0.98%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 0.5% a day on average for past five trading days. | Weekly Trend | LGND declines -1.4% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(57%) XBI(55%) IWC(54%) IWM(53%) | Factors Impacting LGND price | LGND will decline at least -1.28% in a week (0% probabilities). VXX(-21%) TLT(-15%) IFRA(-8%) UUP(-4%) IGOV(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.28% (StdDev 2.56%) | Hourly BBV | 0 () | Intraday Trend | -1.4% | | | |
|
1 - 5 Day Possible Target | $107.33(-5.64%) | 5 Day Moving Average | $111.21(2.27%) | 10 Day Moving Average | $111.99(1.56%) | 20 Day Moving Average | $113.62(0.11%) | To recent high | -12.1% | To recent low | 7.4% | Market Cap | $1.828b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |